Dean, Charles-Sander - College of Agriculture and Life Sciences, Director, Experiment Station, Professor, Animal and Comparative Biomedical Sciences, Professor, BIO5 Institute, Professor, Immunobiology, Vice President, Agriculture - Life and Veterinary Sciences / Cooperative Extension
Associate Professor, BIO5 Institute, Associate Professor, Chemistry and Biochemistry-Sci
We seek to develop tools and strategies to expedite the understanding and treatment of the dengue virus. These advances will be transferable to other areas of virology and biochemistry. Along these lines, we are engaged in three core synergistic projects to answer the following questions: (1) Do unnatural metabolites incorporated into DENV serve as reporters for host-pathogen interactions? (2) What are the host-pathogen interactions in DENV that are targetable for diagnosis or treatment? (3) Is there a chemical reaction between two small molecules that reports on the interaction between DENV and host proteins?
Endowed Chair, Thomas R Brown - Biomedical Engineering, Professor, BIO5 Institute, Professor, Biomedical Engineering, Professor, Electrical and Computer Engineering
Our group develops rapid, inexpensive tools for the immediate discovery and identification of infectious diseases. It is critical for highly populated areas and resource-poor environments to have access to immediate therapeutics to save their populations and prevent the spread of these diseases.
Associate Professor, Animal and Comparative Biomedical Sciences, Associate Professor, BIO5 Institute
Professor, Animal and Comparative Biomedical Sciences, Professor, BIO5 Institute, Professor, Immunobiology
Our research efforts focus on bacteria that cause serious healthcare-associated infections, and those associated with antibiotic use. This infections disproportiOur federally-funded research focuses on infection prevention. Specifically, we study diseases such as Clostridium difficile Infection that affect populations worldwide ("One-Health" issue). Our current efforts are aimed at translating bench-research findings to the bedside. We have recently been awarded two patents for a novel biologic agent invention aimed at preventing bacterial infections in humans as well as food animals.onately affect the elderly, and those with compromised immune systems. One overarching goal of our studies is to develop safe, cost-effective, non-antibiotic interventions to prevent and treat bacterial diarrheas.
Associate Professor, Applied Mathematics - GIDP, Associate Professor, BIO5 Institute, Associate Professor, Biomedical Engineering, Associate Professor, Neuroscience - GIDP, Associate Professor, Optical Sciences, Professor, Medical Imaging
We develop cutting-edge imaging technology, integrating light, ultrasound and electricity, to diagnose and treat diseases ranging from epilepsy to breast cancer. Novel sources for ultrasound contrast include optical and microwave absorption, mechanical strain, and electrical current. We visualize electrical brain “stormsˮ during uncontrollable seizures and envision “smartˮ photoacoustic agents that seek-and-destroy deadly tumors.